(00:32)
Could you let our listeners know a bit about your role and background at Mayo Clinic?
(01:23)
Is there a lot of information sharing between our neurology clinicians and the Alzheimer’s Disease Research Center when it comes to test development?
(01:50)
Can you give us a brief overview of the test?
(03:17)
Is a cerebral spinal fluid test for NFLC already on the market?
(04:41)
How has Mayo Clinic been able to launch this test in blood?
(05:49)
What is a laboratory developed test, and what does it mean for physicians?
(07:00)
Do we have a high degree of confidence that physicians will get an actionable result from this blood test?
(07:45)
How will Mayo Clinic Laboratories help physicians interpret the test results?
(09:15)
For which patients is this test most appropriate?
(10:59)
How might patients benefit from this test?
(11:46)
How can this test help physicians to know which treatment path to pursue?
(12:33)
How else might this test benefit patients?
(13:49)
What about this test excites you most?
